button bars forest bayes pooled summary circles
 
deaths (OS)

mHCC - 1st line (L1) metastatic/advanced hepatocellular cancer (mHCC) mHCC - 1st line (L1)

versus sorafenib
atezolizumab plus bevacizumab vs. sorafenib 1 -1082 [-1971; -194] /10000
96/336 vs. 65/165

mHCC - 2nd line (L2) metastatic/advanced hepatocellular cancer (mHCC) mHCC - 2nd line (L2)

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons